Different Therapeutic Paths (Colchicine vs. Anakinra) in Two Patients With Schnitzler’s Syndrome

Archives of Rheumatology - Turkey
doi 10.5606/archrheumatol.2016.6000
Full Text
Abstract

Available in full text

Categories
Rheumatology
Date
Authors
Publisher

Baycinar Tibbi Yayincilik

Related search

P01-031 – Anakinra for Colchicine Resistant FMF

Pediatric Rheumatology
ImmunologyPediatricsRheumatologyAllergyPerinatologyChild Health
2013English

Assessment of Effectiveness of Anakinra and Canakinumab in Patients With Colchicine-Resistant/Unresponsive Familial Mediterranean Fever

Advances in Rheumatology
Rheumatology
2020English

OR5-002 – In Vitro Studies in Schnitzler’s Syndrome

Pediatric Rheumatology
ImmunologyPediatricsRheumatologyAllergyPerinatologyChild Health
2013English

Colchicine Plus Dapsone in Colchicine‐Resistant FMF Patients

Case Reports in Rheumatology
2019English

Block vs. Traditional Periodization of HIT: Two Different Paths to Success for the World’s Best Cross-Country Skier

Frontiers in Physiology
Physiology
2019English

Pharmacokinetics of Anakinra in Subjects of Heavier vs. Lighter Body Weights

Clinical and Translational Science
GeneticsMolecular BiologyPharmacologyBiochemistryNeuroscienceMedicineToxicologyPharmaceutics
2019English

Anakinra for Colchicine-Resistant Familial Mediterranean Fever: A Randomized, Double-Blind, Placebo-Controlled Trial

Arthritis and Rheumatology
RheumatologyAllergyImmunology
2017English

Comparison of Early vs. Delayed Anakinra Treatment in Patients With Adult Onset Still's Disease and Effect on Clinical and Laboratory Outcomes

Frontiers in Medicine
Medicine
2020English

Macrophage Activation Syndrome Associated With Adult-Onset Still’s Disease Successfully Treated With Anakinra

Case Reports in Rheumatology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy